​David L. Glandorf is an associate in Gibson Dunn’s Denver office where he currently practices in the Firm’s Litigation Department and works with the Firm’s Intellectual Property Practice Group. Prior to attending law school, he served as an instructor in general chemistry at the University of Colorado.

Dr. Glandorf received his law degree in 2007 from Harvard Law School. While at Harvard, he served as Basic Training Director for the Harvard Mediation Program, as well as the Sports Chair for the Harvard Committee on Sports and Entertainment Law, and he worked on the Journal of Law and Technology. In addition, Dr. Glandorf holds a Ph.D. in physical chemistry from the University of Colorado, and a B.S. from Wheaton College in Illinois. More recently, Dr. Glandorf has taught patent litigation as part of the Intellectual Property Capstone course at the University of Denver Sturm College of Law.

Among the various matters during his time at Gibson Dunn, Dr. Glandorf has represented Tessera, Inc. in a patent infringement trial before the International Trade Commission involving semiconductor technology. He has represented Sharp Corporation before the International Trade Commission in matters involving on-screen program guides and liquid crystal display technology.   Other technological patent disputes in which Dr. Glandorf has been involved include matters representing Amazon.com, Inc., Hewlett-Packard, and Paramount Pictures in U.S. District Court.

Dr. Glandorf further specializes in the representation of pharmaceutical clients in intellectual property disputes and counseling, including Hatch-Waxman litigation. His clients in this area have included Depomed, Merck Serono, Sanofi-Aventis, Pfizer, and Novo Nordisk.

Dr. Glandorf has also drafted and litigated petitions for Inter Partes Reviews before the USPTO Patent Trial and Appeals Board including matters for Roquette Frères and Agilent Instruments.

Dr. Glandorf is admitted to practice law in the State of Colorado and before the USPTO.